128 related articles for article (PubMed ID: 34383797)
21. HIV viral suppression in TREAT Asia HIV Observational Database enrolled adults on antiretroviral therapy at the Social Health Clinic, the National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
Boettiger DC; Khol V; Durier N; Law M; Sun LP
Antivir Ther; 2016; 21(8):725-730. PubMed ID: 27124891
[TBL] [Abstract][Full Text] [Related]
22. A modified HIV continuum of care: A six-year evaluation of a viral load cascade at a hospital-based clinic in Kingston, Jamaica.
Barrow GJ; Brandeau ML
Int J STD AIDS; 2019 Jul; 30(8):748-755. PubMed ID: 31072281
[TBL] [Abstract][Full Text] [Related]
23. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams E
Cochrane Database Syst Rev; 2014 May; 2014(5):CD004772. PubMed ID: 24852077
[TBL] [Abstract][Full Text] [Related]
24. Population uptake and effectiveness of test-and-treat antiretroviral therapy guidelines for preventing the global spread of HIV: an ecological cross-national analysis.
Mendez-Lopez A; McKee M; Stuckler D; Granich R; Gupta S; Noori T; Semenza JC
HIV Med; 2019 Sep; 20(8):501-512. PubMed ID: 31140715
[TBL] [Abstract][Full Text] [Related]
25. High Coverage of Antiretroviral Treatment With Annual Home-Based HIV Testing, Follow-up Linkage Services, and Implementation of Test and Start: Findings From the Chókwè Health Demographic Surveillance System, Mozambique, 2014-2019.
Pathmanathan I; Nelson R; de Louvado A; Thompson R; Pals S; Casavant I; Cardoso MJA; Ujamaa D; Bonzela J; Mikusova S; Chivurre V; Tamele S; Sleeman K; Zhang G; Zeh C; Dobbs T; Vubil A; Auld A; Briggs-Hagen M; Vergara A; Couto A; MacKellar D
J Acquir Immune Defic Syndr; 2021 Apr; 86(4):e97-e105. PubMed ID: 33252546
[TBL] [Abstract][Full Text] [Related]
26. Long-term immune and virological response in HIV-infected patients receiving antiretroviral therapy.
Silveira MP; Silveira CP; Guttier MC; Page K; Moreira LB
J Clin Pharm Ther; 2016 Dec; 41(6):689-694. PubMed ID: 27676134
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with viral suppression among HIV-positive Kenyan gay and bisexual men who have sex with men.
Kunzweiler CP; Bailey RC; Mehta SD; Okall DO; Obondi E; Djomand G; Nyunya BO; Otieno FO; Graham SM
AIDS Care; 2018 Aug; 30(sup5):S76-S88. PubMed ID: 30897938
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and indicators of viral suppression among persons with diagnosed HIV infection retained in care - Georgia, 2010.
Edison L; Hughes D; Drenzek C; Kelly J;
MMWR Morb Mortal Wkly Rep; 2014 Jan; 63(3):55-8. PubMed ID: 24452133
[TBL] [Abstract][Full Text] [Related]
29. Two-fold increase in the HIV viral load suppression rate along with decreased incidence over six years in Ndhiwa sub-county, Kenya.
Conan N; Badawi M; Chihana ML; Wanjala S; Kingwara L; Mambula C; Ngugi C; Okomo G; Opollo V; Salumu L; Nesbitt R; Szumilin E; Huerga H
Trop Med Int Health; 2021 Dec; 26(12):1609-1615. PubMed ID: 34637172
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the care cascade after antiretroviral therapy initiation in Latin America.
Wolff MJ; Cortes CP; Mejìa FA; Padgett D; Belaunzarán-Zamudio P; Grinsztejn B; Giganti MJ; McGowan CC; Rebeiro PF;
Int J STD AIDS; 2018 Jan; 29(1):4-12. PubMed ID: 28618980
[TBL] [Abstract][Full Text] [Related]
31. How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa?
Euvrard J; Schulz T; Hilderbrand K; Bosland M; Osler M; Boulle A; Davies MA
S Afr Med J; 2019 Feb; 109(3):174-177. PubMed ID: 30834874
[TBL] [Abstract][Full Text] [Related]
32. Temporal dynamics and drivers of durable HIV viral load suppression and persistent high- and low-level viraemia during Universal Test and Treat scale-up in Uganda: a population-based study.
Rosen JG; Ssekubugu R; Chang LW; Ssempijja V; Galiwango RM; Ssekasanvu J; Ndyanabo A; Kisakye A; Nakigozi G; Rucinski KB; Patel EU; Kennedy CE; Nalugoda F; Kigozi G; Ratmann O; Nelson LJ; Mills LA; Kabatesi D; Tobian AAR; Quinn TC; Kagaayi J; Reynolds SJ; Grabowski MK
J Int AIDS Soc; 2024 Feb; 27(2):e26200. PubMed ID: 38332519
[TBL] [Abstract][Full Text] [Related]
33. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.
Phillips AN; Staszewski S; Weber R; Kirk O; Francioli P; Miller V; Vernazza P; Lundgren JD; Ledergerber B; ; ;
JAMA; 2001 Nov; 286(20):2560-7. PubMed ID: 11722270
[TBL] [Abstract][Full Text] [Related]
34. Treatment outcome of the implementation of HIV test and treat policy at The AIDs Support Organization (TASO) Tororo clinic, Eastern Uganda: A retrospective cohort study.
Opito R; Mpagi J; Bwayo D; Okello F; Mugisha K; Napyo A
PLoS One; 2020; 15(9):e0239087. PubMed ID: 32960927
[TBL] [Abstract][Full Text] [Related]
35. A randomized controlled trial evaluating the effects of a family-centered HIV care model on viral suppression and retention in care of HIV-positive children in Eswatini.
Ashburn K; Chouraya C; Khumalo P; Mpango L; Mthethwa N; Machekano R; Guay L; Mofenson LM
PLoS One; 2021; 16(8):e0256256. PubMed ID: 34428241
[TBL] [Abstract][Full Text] [Related]
36. Timeliness of Human Immunodeficiency Virus Diagnosis and Antiretroviral Treatment Initiation in the Era of Universal Testing and Treatment.
Robertson MM; Braunstein SL; Hoover DR; Li S; Nash D
J Infect Dis; 2019 Jul; 220(4):648-656. PubMed ID: 30997508
[TBL] [Abstract][Full Text] [Related]
37. HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study.
Dorward J; Sookrajh Y; Gate K; Khubone T; Mtshaka N; Mlisana K; Ngobese H; Yende-Zuma N; Garrett N
J Int AIDS Soc; 2020 Apr; 23(4):e25479. PubMed ID: 32319203
[TBL] [Abstract][Full Text] [Related]
38. High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa.
van Rooyen H; Barnabas RV; Baeten JM; Phakathi Z; Joseph P; Krows M; Hong T; Murnane PM; Hughes J; Celum C
J Acquir Immune Defic Syndr; 2013 Sep; 64(1):e1-8. PubMed ID: 23714740
[TBL] [Abstract][Full Text] [Related]
39. Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa.
Zaniewski E; Dao Ostinelli CH; Chammartin F; Maxwell N; Davies MA; Euvrard J; van Dijk J; Bosomprah S; Phiri S; Tanser F; Sipambo N; Muhairwe J; Fatti G; Prozesky H; Wood R; Ford N; Fox MP; Egger M
J Int AIDS Soc; 2020 Jul; 23(7):e25546. PubMed ID: 32640106
[TBL] [Abstract][Full Text] [Related]
40. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
